MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
about
Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionOsteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesIntegrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and oldDepletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancerOsteosarcomagenesis: modeling cancer initiation in the mouse.Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma.MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.A multilevel model to address batch effects in copy number estimation using SNP arrays.A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells.Identification of putative target genes of the transcription factor RUNX2.Apoptotic cell signaling in cancer progression and therapySurvivin and IAP proteins in cell-death mechanismsA new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53.IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.IAP antagonists sensitize murine osteosarcoma cells to killing by TNFαHeritable one-hit events defining cancer prevention?The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular StresscIAP2 as a therapeutic target in colorectal cancer and other malignancies.IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA.Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis.A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203.Energy stress-induced lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and inhibits osteosarcoma progression.
P2860
Q24306110-369FF4C3-1F4D-4F9A-856E-395565FBE039Q26745742-8F3BA009-1146-4B71-AD1F-1AFD4EEC3901Q28396741-94FE38CB-4D65-46F7-B638-FEAAFEEECB73Q28539741-BE47950C-96F2-4202-BD4C-0DF970F242E7Q30476415-8DB32B34-A78C-4859-8FFC-4EFBB22D7416Q33632016-D40122A8-BBEC-4721-87DD-342E2AC2D5C4Q33747680-3D829D96-D67F-4167-8FC6-59133A03DC8DQ34211970-33771980-008C-4372-B8FE-9491DCDE9A4FQ34259434-31964332-B32A-4091-8E89-52EE74B552F4Q34425384-F3B2C086-184A-4253-AA83-34033E7A541EQ34575966-0C402EC3-D7B4-4991-9515-573355812FE7Q34580883-F431C2D7-3E31-4DED-A73F-15AFF1652194Q35027488-E745F6BC-DB33-439D-8712-F9320AB39B93Q35070834-40D38522-6D56-409B-8064-ADE0C7FC6A86Q35088734-A2D42769-5FA8-4847-8731-323A04C93754Q35414780-617E41E0-7489-443A-8DB4-8D7E515EA5B1Q35640128-BC082545-06B2-41FE-90E2-CD87BF2AC861Q36608717-785F8964-AAB7-4592-996B-70F4B5126A40Q36750689-49BC4BAE-D5E2-4CE6-95A9-4877F409BF21Q37376164-62B188FA-D278-4280-87F2-77866FD0C2C2Q37396894-8652A17A-7BF6-4B7C-A342-960DA8807E29Q37512362-3604EF16-31E1-4260-ADF1-D332A943923AQ37605889-79EE3134-67AC-49D7-908A-0276E8163495Q38134633-3B1B1E3F-9F8A-45EA-BE8E-E98FF16B7653Q38794695-467B85B1-9E78-4612-A0A9-BDF15AF8CB88Q38833391-7B0D9DA4-354E-41AC-A075-BE0A0A8DB832Q38860724-D8F02D3C-D9D1-4790-AC0E-C3DB44F77CF3Q38904937-3AA2AC64-3080-4A55-93E6-380C4E53964FQ38931801-830685A5-F027-439D-B1D1-C44DD9720CEDQ39266738-8A80DE63-D3C9-4D8F-BFE1-E355DE21B3E6Q41380246-E71F4B34-B33C-49EB-927A-A42521F9594FQ41854551-B8D8BAA8-8428-438F-B974-B400951A334AQ42251412-0DE200E0-0443-4304-B472-AE2B5421ED54Q44106136-6EBDEDF4-577D-48B5-A4FF-F4FBD46ED946Q44481241-4DE0D98A-DFED-43C4-BCA4-A1B10B3BAD3FQ47119874-74CD7CFD-C03B-4ED8-A4BB-C3E3DB0AEE2CQ50067715-D7334572-A067-4996-85FE-0C669888A419Q54378331-7D8EF762-40A1-457B-B957-75C60F9EF898Q54970122-1B74E951-D76F-4186-B64C-3318213154A6Q55026439-3240B172-A087-433D-9A3A-91BA38576A91
P2860
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@ast
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@en
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@nl
type
label
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@ast
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@en
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@nl
prefLabel
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@ast
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@en
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@nl
P2093
P2860
P1433
P1476
MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.
@en
P2093
Alan J Herron
Ching C Lau
Jianhe Shen
Lars Zender
Lawrence A Donehower
Scott W Lowe
Tajhal Dayaram
Tsz-Kwong Man
Wei-Wen Cai
P2860
P304
P356
10.1158/0008-5472.CAN-08-2929
P407
P50
P577
2009-03-10T00:00:00Z